Curie Capital logo

Curie Capital

North America, Missouri, United States, Netherlands

Description

Curie Capital is a life science focused venture capital firm

Investor Profile

Curie Capital has made 10 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Seed (20%)
  • Series B (20%)
  • Series Unknown (10%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Biopharma
  • Neuroscience
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Curie Capital frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
F
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
Co-Investments: 1
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 1
Swanbridge Capital
Europe, Zuid-Holland, The Netherlands, Rotterdam
Co-Investments: 1
BOM
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 4
Utrecht Health Seed Fund
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2
Co-Investments: 1
BB
Europe, Noord-Brabant, The Netherlands, Tilburg
Co-Investments: 3
Holland Capital
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4

What are some of recent deals done by Curie Capital?

Sirius Medical

Eindhoven, Noord-Brabant, The Netherlands

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment.

Health CareMedicalMedical Device
Series UnknownFeb 4, 2025
Amount Raised: $10,332,350
Citryll

Oss, Noord-Brabant, The Netherlands

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

BiopharmaBiotechnologyMedicalMedical DeviceNeuroscience
Series BDec 9, 2024
Amount Raised: $89,720,936
Flindr Therapeutics

Amsterdam, Noord-Holland, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

BiotechnologyHealth CareTherapeutics
Series AApr 24, 2024
Amount Raised: $21,400,056
Sirius Medical

Eindhoven, Noord-Brabant, The Netherlands

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment.

Health CareMedicalMedical Device
Series BMar 21, 2023
Amount Raised: $12,927,830
Cleara Biotech

Utrecht, Utrecht, The Netherlands

Cleara is developing therapeutics to eliminate senescent cells.

Biotechnology
SeedSep 28, 2022
Amount Raised: $2,500,000
TargED Biopharmaceuticals

Utrecht, Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AFeb 19, 2022
Amount Raised: $44,156,009
Sirius Medical

Eindhoven, Noord-Brabant, The Netherlands

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment.

Health CareMedicalMedical Device
Series ADec 14, 2021
TargED Biopharmaceuticals

Utrecht, Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

BiopharmaBiotechnologyHealth CarePharmaceutical
SeedNov 24, 2020
Amount Raised: $1,606,158
Sirius Medical

Eindhoven, Noord-Brabant, The Netherlands

Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment.

Health CareMedicalMedical Device
Series AJul 13, 2020
Amount Raised: $4,991,781
Citryll

Oss, Noord-Brabant, The Netherlands

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

BiopharmaBiotechnologyMedicalMedical DeviceNeuroscience
Series AJul 3, 2019